Similar outcome of tricuspid valve repair and replacement for isolated tricuspid infective endocarditis.
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
ppublish
Résumé
To compare early and late mortality of acute isolated tricuspid valve infective endocarditis (TVIE) treated with valve repair or replacement. Patients who were surgically treated for TVIE from 1983 to 2018 were retrieved from the Italian Registry for Surgical Treatment of Valve and Prosthesis Infective Endocarditis. All the patients were followed up by means of phone interview or calling patient referral physicians or cardiologists. Kaplan-Meier method was used to assess late survival and survival free from TVIE recurrence with log-rank test for univariate comparison. The primary end points were early mortality (30 days after surgery) and long-term survival free from TVIE recurrence. A total of 4084 patients were included in the registry. Among them, 149 patients were included in the study. Overall, 77 (51.7%) underwent TV repair and 72 (48.3%) TV replacement. Early mortality was 9% (13 patients). Expected early mortality according to EndoSCORE was 12%. The TV repair showed lower mortality and major complication rate (7% and 16%), compared with TV replacement (11% and 25%), but statistical significance was not reached. Median follow-up was 19.1 years (14.3-23.8). Late deaths were 30 and IE recurrences were 5. No difference in cardiac survival free from IE was found between the two groups after 20 years (80 ± 6% Repair Group vs 59 ± 13% Replacement Group, P = 0.3). Overall results indicate that once surgically addressed, TVIE has a low recurrence rate and excellent survival, apparently regardless of the type of surgery used to treat it.
Identifiants
pubmed: 35645032
doi: 10.2459/JCM.0000000000001310
pii: 01244665-202206000-00009
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
406-413Informations de copyright
Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.
Références
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020; 143: e35-e71.
Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective endocarditis. J Am Coll Cardiol 2017; 69:325–344.
Yong MS, Coffey S, Prendergast BD, et al. Surgical management of tricuspid valve endocarditis in the current era: a review. Int J Cardiol 2016; 202:44–48.
Iftikhar SF, Ahmad F. Tricuspid Valve Endocarditis. StatPearls, Treasure Island (FL): StatPearls Publishing; 2020.
Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015; 65:2070–2076.
Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56:1149–1157.
Kim JB, Ejiofor JI, Yammine M, et al. Surgical outcomes of infective endocarditis among intravenous drug users. J Thorac Cardiovasc Surg 2016; 152:832–841. e1.
Weber C, Gassa A, Eghbalzadeh K, et al. Characteristics and outcomes of patients with right-sided endocarditis undergoing cardiac surgery. Ann Cardiothorac Surg 2019; 8:645–653.
Witten JC, Hussain ST, Shrestha NK, et al. Surgical treatment of right-sided infective endocarditis. J Thorac Cardiovasc Surg 2019; 157:1418–1427. e14.
Lee H-A, Chou A-H, Wu VC-C, et al. Nationwide cohort study of tricuspid valve repair versus replacement for infective endocarditis. Eur J Cardiothorac Surg 2021; 59:878–886.
Di Mauro M, Foschi M, Dato GMA, et al. Surgical treatment of isolated tricuspid valve infective endocarditis: 25-year results from a multicenter registry. Int J Cardiol 2019; 292:62–67.
Slaughter MS, Badhwar V, Ising M, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: an analysis of the Society of Thoracic Surgeons national database. J Thorac Cardiovasc Surg 2021; 161:1227–1235.
Yanagawa B, Elbatarny M, Verma S, et al. Surgical management of tricuspid valve infective endocarditis: a systematic review and meta-analysis. Ann Thorac Surg 2018; 106:708–714.
Di Mauro M, Dato GMA, Barili F, et al. A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE. Int J Cardiol 2017; 241:97–102.
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36:3075–3128.
Shmueli H, Thomas F, Flint N, Setia G, Janjic A, Siegel RJ. Right-sided infective endocarditis 2020: challenges and updates in diagnosis and treatment. J Am Heart Assoc 2020; 9:e017293.
Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. JAMA 2018; 320:72–83.
Hussain ST, Witten J, Shrestha NK, Blackstone EH, Pettersson GB. Tricuspid valve endocarditis. Ann Cardiothorac Surg 2017; 6:255–261.
Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Arch Intern Med 2009; 169:463–473.
Corte AD, Della Corte A, Di Mauro M, et al. Surgery for prosthetic valve endocarditis: a retrospective study of a national registry. Eur J Cardio-Thorac Surg 2017; 52:105–111.
Brescia AA, Watt TMF, Williams AM, Romano MA, Bolling SF. Tricuspid valve leaflet repair and augmentation for infective endocarditis. Oper Tech Thorac Cardiovasc Surg 2019; 24:206–218.
Gaca JG, Sheng S, Daneshmand M, et al. Current outcomes for tricuspid valve infective endocarditis surgery in North America. Ann Thorac Surg 2013; 96:1374–1381.
Scully HE, Armstrong CS. Tricuspid valve replacement: fifteen years of experience with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 1995; 109:1035–1041.
Morimoto N, Matsushima S, Aoki M, et al. Long-term results of bioprosthetic tricuspid valve replacement: an analysis of 25 years of experience. Gen Thorac Cardiovasc Surg 2013; 61:133–138.
Lee HA, Chou AH, Wu VC, et al. Nationwide cohort study of tricuspid valve repair versus replacement for infective endocarditis. Eur J Cardiothorac Surg 2021; 59:878–886.
Parolari A, Barili F, Pilozzi A, Pacini D. Ring or suture annuloplasty for tricuspid regurgitation? A meta-analysis review. Ann Thorac Surg 2014; 98:2255–2263.
Tarola CL, Losenno KL, Chu MW. Complex tricuspid valve repair for infective endocarditis: leaflet augmentation, chordae and annular reconstruction. Multimed Man Cardiothorac Surg 2015; 2015:mmv006.
Wiedemann D, Rupprechter V, Mascherbauer J, et al. Tricuspid valve replacement: results of an orphan procedure – which is the best prosthesis? J Cardiovasc Surg 2018; 59:626–632.
Garatti A, Nano G, Bruschi G, et al. Twenty-five year outcomes of tricuspid valve replacement comparing mechanical and biologic prostheses. Ann Thorac Surg 2012; 93:1146–1153.
Flameng W, Hermans H, Verbeken E, Meuris B. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model. J Thorac Cardiovasc Surg 2015; 149:340–345.
Redondo Palacios A, López Menéndez J, Miguelena Hycka J, et al. Which type of valve should we use in tricuspid position? Long-term comparison between mechanical and biological valves. J Cardiovasc Surg 2017; 58:739–746.
Guenther T, Noebauer C, Mazzitelli D, Busch R, Tassani-Prell P, Lange R. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg 2008; 34:402–409.
Chandavimol M, Ngernsritrakul T, Meemook K, et al. Transcatheter tricuspid valve-in-valve implantation for degenerative surgical bio-prosthesis using SAPIEN 3: a case series. Clin Case Rep 2021; 9:e05029.
Ranocchi F, Nicolò F, Russo M, et al. Minimally invasive implantation of a Sapien 3 Ultra Valve in a degenerated tricuspid bioprosthesis. J Card Surg 2020; 35:1371–1374.
Scarsini R, Lunardi M, Pesarini G, et al. Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves. Int J Cardiol 2017; 235:141–146.
Rizzoli G, Vendramin I, Nesseris G, Bottio T, Guglielmi C, Schiavon L. Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg 2004; 77:1607–1614.
Edwards MB, Ratnatunga CP, Dore CJ, Taylor KM. Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry. Eur J Cardiothorac Surg 1998; 14:156–164.
Veve MP, Akhtar Y, McKeown PP, Morelli MK, Shorman MA. Percutaneous mechanical aspiration vs valve surgery for tricuspid-valve endocarditis in drug users. Ann Thorac Surg 2021; 111:1451–1457.
Pfannmueller B, Kahmann M, Davierwala P, et al. Erratum to: Tricuspid valve surgery in patients with isolated tricuspid valve endocarditis: analysis of perioperative parameters and long-term outcomes. 2015 [efirst ahead of print]. Thorac Cardiovasc Surg 2017; 65:e1–e11.
Rundström H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis 2004; 36:674–679.
Chirillo F, Scotton P, Rocco F, et al. Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 2013; 112:1171–1176.
Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169:1290–1298.
Umehara N, Miyata H, Motomura N, Saito S, Yamazaki K. Surgical results of reoperative tricuspid surgery: analysis from the Japan Cardiovascular Surgery Database. Interact CardioVasc Thorac Surg 2014; 19:82–87.